Randomized comparison of whole-body vibration plus usual care versus usual care to improve muscle health in older adults
Official title: Effectiveness of Whole Body Vibration Therapy and Usual Care Compared to Usual Care in Improving Muscle Mass, Strength and Function in Older Adults
Run by Changi General Hospital · NCT07205133 · Data updated 2026-11-12
This study will test whether adding a four-week, three-times-weekly whole-body vibration program to usual care helps pre-frail and mildly frail adults aged 65 and older improve muscle mass, strength, and function.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 65 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Changi General Hospital Academic / other |
| Locations | 1 site (Singapore) |
| Status | Recruiting |
| Started | January 10, 2026 |
| Main results expected | March 31, 2027 |
| Study ends | March 31, 2027 |
| Registry record updated | April 15, 2026 |
| Trial ID | NCT07205133 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are independently ambulant community-dwelling adults aged 65 or older with mild frailty (CFS 3–4), who do not already meet regular exercise thresholds and can travel to the study site.
✕Probably not a fit
People with dementia, recent hospital stays, poorly controlled chronic illnesses, contraindications to whole-body vibration, or more advanced frailty are unlikely to benefit or be eligible for this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized, two-arm trial in which community-dwelling adults aged 65+ with clinical frailty scale scores of 3–4 are allocated to either whole-body vibration therapy plus usual care or to usual care alone. The intervention consists of a progressive 4-week WBVT program delivered three times per week, with measurements taken at baseline and at two post-intervention time points. The primary outcome is change in maximal isometric knee-extension strength from baseline to two weeks after the intervention, and secondary outcomes include appendicular skeletal muscle index, handgrip strength, gait speed, timed chair stands, quality of life, and physical activity level. The trial enrolls about 20 participants per arm and excludes people with dementia, recent hospital admission, poorly controlled chronic disease, or contraindications to vibration therapy.
Why it matters
Potential benefit: If effective, WBVT could offer a lower-burden, easier-to-follow option to help pre-frail older adults gain muscle strength and improve function.
How similar studies have gone: Small prior studies of whole-body vibration have reported improvements in muscle strength and function, but findings are mixed and larger randomized trials remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Healthy Volunteer or Patients aged 65 and above, * Clinical frailty Scale (CFS) score of 3-4, * Independently ambulating without any aid * willingness and consent to participate in the study and ability to travel to the study-site for the measurements and interventions, and * participants with no regular exercise habits (defined as less than 150mins/week of moderate intensity aerobic exercise and less than twice a week of strengthening exercises)for past 3 months. Exclusion Criteria: * current active enrolment into any Day Rehab or community exercise program, * contraindications to WBVT machine usage (see below), * diagnosis of dementia, * history of Diabetes Mellitus * BMI ≤20kg/m2, * recent hospital admissions within the last 3 months, * end stage organ failure, * chronic diseases which are not well managed, for example, poorly controlled hypertension, * New York Heart Association (NYHA) score II and above for patients with history of heart failure and * MUST Score ≥1. Contraindications to WBVT: PRIMARY CONTRAINDICATIONS TO WBVT * Pregnancy * Acute thrombosis (acute vascular occlusion) * Artificial joints in stimulated body regions * Fresh fractures in stimulated body regions * Within 3 months post surgery/procedure and/or any fresh wounds and scars in the stimulated body regions * or if the wound healing is not yet completely finished. SECONDARY CONTRAINDICATIONS TO WBVT * Acute inflammation of the musculoskeletal system, activated arthrosis or * arthropathy (e.g. acute inflammation and swelling in joints). * Acute tendinopathies in stimulated body regions (acute tendonitis) * Acute hernias (tissue ruptures) * Acute discopathy (acute disc-related back problem) * Stone disease of the bile ducts and urinary tract * Rheumatoid Arthritis * Epilepsy due to secondary risk of injury
Where it's running
-
Changi General Hospital
Singapore, Singapore Recruiting
Study contacts
- Study coordinator: Christine Yuanxin Chen, MBBS
- Email: christine.chen.y.x@singhealth.com.sg
- Phone: +65-9030 4976
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Multicomponent prehabilitation for older adults with breast cancer
This program will test whether a multicomponent prehabilitation intervention (home-based or supervised) helps people aged 65 and older with breast cancer improve physical function, recovery after surgery, and quality of life while exploring biological markers that predict who benefits.
-
Longevity Metrics AI/ML Development Study
Researchers are testing AI models that score health screening tests and predict outcomes like life expectancy for adults, using ongoing follow-up data.
-
Acupoint Stimulation and Exercise for Pre-frail Older Adults in Taiwan
This study tests whether combining exercise with daytime and sleep-improving acupoint stimulation helps pre-frail adults 50 and older in Taiwan feel less frail and sleep better.
-
Centenarian cohort in Navarre to study aging and longevity
This study tests what factors help centenarians in Navarre stay healthier as they age and what might explain their exceptional longevity.
-
Health Ahead: Comparing AI vs. Humans for Preventive Health Screening
This study tests AI-assisted screening interpretation against human-only reads to see if automated screening can match or improve current practice for adults, especially in underserved areas.
-
How environment and biology together predict health, aging, and death
Researchers are following adults to see how living conditions and biology together relate to aging and life expectancy, by linking personal health data with environmental and social information over time.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.